Gen-Probe Cultivates Cancer Segment Through Roche HPV DNA Probe Deal
This article was originally published in The Gray Sheet
Executive Summary
A supply and purchase agreement with Roche Molecular Systems for human papillomavirus DNA probes could enable Gen-Probe's fledgling oncology segment to introduce an HPV diagnostic in the U.S. by 2009, CEO Henry Nordhoff stated
You may also be interested in...
Gen-Probe Prepares For West Nile Virus Test Commercial Uptake
Gen-Probe expects an upsurge in revenue from its West Nile Virus blood screening assay shortly after FDA approval, according to CFO and VP-Finance Herm Rosenman
Gen-Probe Prepares For West Nile Virus Test Commercial Uptake
Gen-Probe expects an upsurge in revenue from its West Nile Virus blood screening assay shortly after FDA approval, according to CFO and VP-Finance Herm Rosenman
Digene DTC Campaign Pushes HPV Test Adoption, Consumer Education
Digene will spend up to $6 mil. on a direct-to-consumer advertising campaign aimed at bolstering sales of its DNAwithPap human papillomavirus test, the company said